Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb;5(1):20-28.
doi: 10.1093/gastro/gow045. Epub 2017 Jan 26.

Current status of intestinal and multivisceral transplantation

Affiliations
Review

Current status of intestinal and multivisceral transplantation

Shishira Bharadwaj et al. Gastroenterol Rep (Oxf). 2017 Feb.

Abstract

Clinical-nutritional autonomy is the ultimate goal of patients with intestinal failure (IF). Traditionally, patients with IF have been relegated to lifelong parenteral nutrition (PN) once surgical and medical rehabilitation attempts at intestinal adaptation have failed. Over the past two decades, however, outcome improvements in intestinal transplantation have added another dimension to the therapeutic armamentarium in the field of gut rehabilitation. This has become possible through relentless efforts in the standardization of surgical techniques, advancements in immunosuppressive therapies and induction protocols and improvement in postoperative patient care. Four types of intestinal transplants include isolated small bowel transplant, liver-small bowel transplant, multivisceral transplant and modified multivisceral transplant. Current guidelines restrict intestinal transplantation to patients who have had significant complications from PN including liver failure and repeated infections. From an experimental stage to the currently established therapeutic modality for patients with advanced IF, outcome improvements have also been possible due to the introduction of tacrolimus in the early 1990s. Studies have shown that intestinal transplant is cost-effective within 1-3 years of graft survival compared with PN. Improved survival and quality of life as well as resumption of an oral diet should enable intestinal transplantation to be an important option for patients with IF in addition to continued rehabilitation. Future research should focus on detecting biomarkers of early rejection, enhanced immunosuppression protocols, improved postoperative care and early referral to transplant centers.

Keywords: gut rehabilitation; intestinal failure; intestinal transplant; multivisceral transplant; parenteral nutrition.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Historical timeline of the development of intestinal and multivisceral transplant
Figure 2
Figure 2
Main types of visceral transplantation. A) Intestine alone. B) Modified multivisceral transplant with exclusion of the liver. C) Full multivisceral transplant that includes stomach, duodenum, pancreas, intestine and liver. D) Combined liver and intestine with pancreas.

References

    1. Tocci MJ, Matkovich DA, Collier KA, et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989;143:718–26. - PubMed
    1. Abu-Elmagd KM, Costa G, Bond GJ, et al. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int 2009;22:96–109. - PubMed
    1. Cunliffe RN, Bowling TE. Artificial nutrition support in intestinal failure: principles and practice of parenteral feeding. Clin Colon Rectal Surg 2004;17:99–105. - PMC - PubMed
    1. Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009;250:567–81. - PubMed
    1. Grant D, Abu-Elmagd KM, Reyes J, et al. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 2005;24:607–13. - PMC - PubMed